Live recombinant vector vaccines for veterinary use - Scientific guideline

This guidelines provides guidance on the data to be submitted in the marketing authorisation application for the veterinary live recombinant vector vaccines. 

Keywords: Live, recombinant vector vaccine, veterinary

Current version

Guideline on live recombinant vector vaccines for veterinary use - Revision 1

Adopted Reference Number: EMA/CVMP/IWP/390313/2023 Legal effective date: 05/06/2025

Revision 1

Draft guideline on live recombinant vector vaccines for veterinary use - Revision 1

Draft: consultation closed Consultation dates: 26/01/2024 to 31/05/2024 Reference Number: EMA/CVMP/IWP/390313/2023 Summary:

This guideline provides guidance on the data to be submitted in the marketing authorisation application for the veterinary live recombinant vector vaccines. 

Comments should be provided using this template. The completed comments form should be sent [e-mail]

Overview of comments received on Guideline on live recombinant vector vaccines for veterinary use - Revision 1

Reference Number: EMA/260063/2024

First version

Guideline on live recombinant vector vaccines for veterinary use

Adopted Reference Number: EMEA/CVMP/004/04-FINAL Legal effective date: 08/06/2005

Concept paper for the revision of the guideline on live recombinant vector vaccines for veterinary use

Draft: consultation closed Consultation dates: 23/06/2023 to 22/09/2023 Reference Number: EMA/CVMP/IWP/161133/2023